BRIEF-Orion and Bayer start new phase III study of prostate cancer drug
… in
patients with metastatic hormone-sensitive prostatecancer
* Says new the study will … with newly diagnosed metastatic
hormone-sensitive prostatecancer
* Says new trial is expected …
No comments:
Post a Comment